(0.69%) 5 117.25 points
(0.16%) 38 348 points
(0.93%) 17 731 points
(0.42%) $83.92
(-3.30%) $1.584
(0.80%) $2 361.30
(1.32%) $27.72
(0.65%) $926.50
(-0.01%) $0.932
(0.42%) $11.00
(-0.05%) $0.799
(-0.21%) $91.97
Live Chart Being Loaded With Signals
Nissui Pharmaceutical Co., Ltd. produces, sells, imports, and exports culture media and diagnostics for medical institutions, research organizations, and food industries in Japan and internationally...
Stats | |
---|---|
Today's Volume | 15 400.00 |
Average Volume | 0.00 |
Market Cap | 0.00 |
Last Dividend | ¥20.00 ( 2022-09-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 0.0000163 |
ATR14 | ¥0 (0.00%) |
Nissui Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Nissui Pharmaceutical Financials
Annual | 2022 |
Revenue: | ¥16.66B |
Gross Profit: | ¥5.26B (31.57 %) |
EPS: | ¥127 333 333 |
FY | 2022 |
Revenue: | ¥16.66B |
Gross Profit: | ¥5.26B (31.57 %) |
EPS: | ¥127 333 333 |
FY | 2021 |
Revenue: | ¥12.38B |
Gross Profit: | ¥4.20B (33.90 %) |
EPS: | ¥71 190 746 |
FY | 2020 |
Revenue: | ¥12.77B |
Gross Profit: | ¥5.73B (44.83 %) |
EPS: | ¥44 054 372 |
Financial Reports:
No articles found.
Nissui Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥20.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥1.000 | 2001-03-27 |
Last Dividend | ¥20.00 | 2022-09-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 38 | -- |
Total Paid Out | ¥454.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.24 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 1.462 | |
Div. Directional Score | 6.19 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8230.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
7606.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
6803.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
6143.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
4849.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4055.T | Ex Dividend Junior | 2023-11-29 | Annually | 0 | 0.00% | |
3280.T | Ex Dividend Junior | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
2311.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
9260.T | Ex Dividend Junior | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
8008.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0688 | 1.500 | 8.62 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0310 | 1.200 | 8.97 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0352 | 1.500 | -0.720 | -1.080 | [0.1 - 1] |
payoutRatioTTM | 0.875 | -1.000 | 1.248 | -1.248 | [0 - 1] |
currentRatioTTM | 8.29 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.255 | 0.800 | 7.32 | 5.86 | [0.8 - 2.5] |
cashRatioTTM | 1.248 | 1.500 | 4.18 | 6.27 | [0.2 - 2] |
debtRatioTTM | 0.00306 | -1.500 | 9.95 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 24.23 | 1.000 | 2.14 | 2.14 | [3 - 30] |
operatingCashFlowPerShareTTM | 111 778 000 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 100 889 000 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00347 | -1.500 | 9.99 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.316 | 1.000 | 8.07 | 8.07 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.103 | 1.000 | 9.93 | 9.93 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 8.90 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.451 | 0.800 | -0.326 | -0.261 | [0.5 - 2] |
Total Score | 10.92 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 0.0000135 | 1.000 | -0.101 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0352 | 2.50 | -0.463 | -1.080 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 100 889 000 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 111 778 000 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.875 | 1.500 | 1.248 | -1.248 | [0 - 1] |
pegRatioTTM | 0.0000002 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0604 | 1.000 | -0.990 | 0 | [0.1 - 0.5] |
Total Score | 1.462 |
Nissui Pharmaceutical
Nissui Pharmaceutical Co., Ltd. produces, sells, imports, and exports culture media and diagnostics for medical institutions, research organizations, and food industries in Japan and internationally. It offers in vitro diagnostics and medical devices; culture media for microbiological testing; products for antimicrobial susceptibility tests, microorganism identification, and immunological tests; and quality control serum, which is used for ensuring the accuracy of clinical diagnoses. In addition,, the company provides microbiological testing products for food poisoning detection; immunosorbent assays for the detection of allergies to food items, such as eggs, wheat, milk, shrimp, crabs, buckwheat, peanuts, etc.; and culture media and reagents for regenerative medicine. Further, it supplies testing agents and bulk products to diagnostic agent manufacturers; and CompactDry, a dry medium that is used for coliform counting for food manufacturers. The company was formerly known as Nissan Research Institute Co., Ltd. and changed its name to Nissui Pharmaceutical Co., Ltd. in 1962. Nissui Pharmaceutical Co., Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators